A detailed history of Cwm, LLC transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 150 shares of MCRB stock, worth $138. This represents 0.0% of its overall portfolio holdings.

Number of Shares
150
Previous 108 38.89%
Holding current value
$138
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

BUY
$0.56 - $1.19 $23 - $49
42 Added 38.89%
150 $0
Q1 2024

Apr 05, 2024

BUY
$0.75 - $1.56 $81 - $168
108 New
108 $0
Q2 2022

Jul 28, 2022

SELL
$2.7 - $7.62 $607 - $1,714
-225 Closed
0 $0
Q1 2022

Apr 21, 2022

BUY
$6.3 - $8.84 $1,417 - $1,989
225 New
225 $2,000

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $114M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.